Proteomic analysis of gingival crevicular fluid for discovery of novel periodontal disease markers

Proteomics

Volumn 12, Issue 13, 2012, Pages 2190-2202

  Tsuchida, Sachio ^a   Satoh, Mamoru ^a,b   Umemura, Hiroshi ^a,b   Sogawa, Kazuyuki ^a,b   Kawashima, Yusuke ^c   Kado, Sayaka ^a   Sawai, Setsu ^a,b   Nishimura, Motoi ^a,b   Kodera, Yoshio ^b,c   Matsushita, Kazuyuki ^a,b   Nomura, Fumio ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Biomedicine; Gingival crevicular fluid; Periodontal disease

Indexed keywords

AGAROSE; APOLIPOPROTEIN A1; DERMCIDIN; SUPEROXIDE DISMUTASE; UREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GINGIVA; GINGIVITIS; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SALIVA ANALYSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; ULTRAFILTRATION;

ADULT; APOLIPOPROTEIN A-I; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; PEPTIDES; PERIODONTAL DISEASES; PROTEINS; PROTEOMICS; SUPEROXIDE DISMUTASE; TANDEM MASS SPECTROMETRY;

EID: 84863997736     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100655     Document Type: Article

References (40)

1. Schroeder, H. E., Listgarten, M. A., The gingival tissues: the architecture of periodontal protection. Periodontol 2000. 1997, 13, 91-120.
2. Listgarten, M. A., Pathogenesis of periodontitis. J. Clin. Periodontol. 1986, 13, 418-430.
3. D'Aiuto, F., Nibali, L., Parkar, M., Suvan, J. et al., Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J. Dent. Res. 2005, 84, 269-273.
4. D'Aiuto, F., Parkar, M., Andreou, G., Suvan, J. et al., Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J. Dent. Res. 2004, 83, 156-160.
5. Adonogianaki, E., Mooney, J., Kinane, D. F., Detection of stable and active periodontitis sites by clinical assessment and gingival crevicular acute-phase protein levels. J. Periodontal. Res. 1996, 31, 135-143.
6. Sakallioǧlu, E. E., Lütfioǧlu, M., Sakallioǧlu, U., Diraman, E. et al., Fluid dynamics of gingiva in diabetic and systemically healthy periodontitis patients. Arch. Oral. Biol. 2008, 53, 646-651.
7. Tezal, M., Scannapieco, F. A., Wactawski-Wende, J., Grossi, S. G. et al., Supragingival plaque may modify the effects of subgingival bacteria on attachment loss. J. Periodontol. 2006, 77, 808-813.
8. Curtis, M. A., Griffiths, G. S., Price, S. J., Coulthurst, S. K. et al., The total protein concentration of gingival crevicular fluid. Variation with sampling time and gingival inflammation. J. Clin. Periodontol. 1988, 15, 628-632.
9. Figueredo, C. M., Areas, A., Miranda, L. A., Fischer, R. G. et al., The short-term effectiveness of non-surgical treatment in reducing protease activity in gingival crevicular fluid from chronic periodontitis patients. J. Clin. Periodontol. 2004, 31, 615-669.
10. Golub, L. M., Kleinberg, I., Gingival crevicular fluid: a new diagnostic aid in managing the periodontal patient. Oral. Sci. Rev. 1976, 8, 49-61.
11. Lamster, I. B., Ahlo, J. K., Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Ann. NY Acad. Sci. 2007, 1098, 216-229.
12. Oh-Ishi, M., Maeda, T., Disease proteomics of high-molecular-mass proteins by two-dimensional gel electrophoresis with agarose gels in the first dimension (Agarose 2-DE). J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2007, 849, 211-222.
13. Seimiya, M., Tomonaga, T., Matsushita, K., Nomura, F. et al., Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase. Hepatology 2008, 48, 519-530.
14. E (gingival exudatome). J. Proteome. Res. 2010, 9, 2191-2199.
15. Löe, H., Silness, J., Periodontal disease in pregnancy. I. Prevalence and severity. Acta. Odontol. Scand. 1963, 21, 533-551.
16. Löe, H., The gingival index, the plaque index and the retention index systems. J. Periodontol. 1967, 38, 610-616.
17. Armitage, G. C., Development of a classification system for periodontal diseases and conditions. Ann. Periodontol. 1999, 4, 1-6.
18. Türkoǧlu, O., Emingil, G., Kütükçüler, N., Atilla, G., Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. J. Periodontol. 2009, 80, 969-976.
19. Goutoudi, P., Diza, E., Arvanitidou, M., Effect of periodontal therapy on crevicular fluid interleukin-1beta and interleukin-10 levels in chronic periodontitis. J. Dent. 2004, 32, 511-520.
20. Kunimatsu, K., Mine, N., Muraoka, Y., Kato, I. et al., Identification and possible function of cathepsin G in gingival crevicular fluid from chronic adult periodontitis patients and from experimental gingivitis subjects. J. Periodontal Res. 1995, 30, 51-57.
21. Lah, T. T., Babnik, J., Schiffmann, E., Turk, V. et al., Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease. J. Periodontol. 1993, 64, 485-491.
22. Surna, A., Kubilius, R., Sakalauskiene, J., Vitkauskiene, A. et al., Lysozyme and microbiota in relation to gingivitis and periodontitis. Med. Sci. Monit. 2009, 15, 66-73.
23. Sorsa, T., Tjäderhane, L., Konttinen, Y. T., Lauhio, A. et al., Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann. Med. 2006, 38, 306-321.
24. Nonnenmacher, C., Helms, K., Bacher, M., Nüsing, R. M. et al., Effect of age on gingival crevicular fluid concentrations of MIF and PGE2. J. Dent. Res. 2009, 88, 639-643.
25. Krayer, J. W., Emerson, D. L., Goldschmidt-Clermont, P. J., Nel, A. E. et al., Qualitative and quantitative studies of Gc (vitamin D-binding protein) in normal subjects and patients with periodontal disease. J. Periodontal Res. 1987, 22, 259-263.
26. Verstappen, J., Von den Hoff, J. W., Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J. Dent. Res. 2006, 85, 1074-1084.
27. Kontush, A., Chapman, M. J., Antiatherogenic small, dense HDL-guardian angel of the arterial wall? Nat. Clin. Pract. Cardiovasc. Med. 2006, 3, 144-153.
28. Zelko, I. N., Mariani, T. J., Folz, R. J., Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 2002, 33, 337-349.
29. Schittek, B., Hipfel, R., Sauer, B., Bauer, J. et al., Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat. Immunol. 2001, 12, 1133-1137.
30. Hartroth, B., Seyfahrt, I., Conrads, G., Sampling of periodontal pathogens by paper points: evaluation of basic parameters. Oral. Microbiol. Immunol. 1999, 14, 326-330.
31. Kardeşler, L., Buduneli, N., Biyikoǧlu, B., Cetinkalp, S. et al., Gingival crevicular fluid PGE2, IL-1beta, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease. Clin. Biochem. 2008, 41, 863-868.
32. Leitch, J. M., Yick, P. J., Culotta, V. C., The right to choose: multiple pathways for activating copper, zinc superoxide dismutase. J. Biol.Chem. 2009, 284, 24679-24683.
33. Zhang, C., Walker, L. M., Hinson, J. A., Mayeux, P. R., Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition. J. Pharmacol. Exp. Ther. 2000, 293, 968-972.
34. Zhang, C., Walker, L. M., Mayeux, P. R., Role of nitric oxide in lipopolysaccharide-induced oxidant stress in the rat kidney. Biochem. Pharmacol. 2000, 59, 203-209.
35. Kimura, S., Yonemura, T., Kaya, H., Increased oxidative product formation by peripheral blood polymorphonuclear leukocytes in human periodontal diseases. J. Periodontal. Res. 1993, 28, 197-203.
36. Akalin, F. A., Toklu, E., Renda, N., Analysis of superoxide dismutase activity levels in gingiva and gingival crevicular fluid in patients with chronic periodontitis and periodontally healthy controls. J. Clin. Periodontol. 2005, 32, 238-243.
37. O'Brien-Simpson, N. M., Pathirana, R. D., Paolini, R. A., Chen, Y. Y. et al., An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J. Immunol. 2005, 175, 3980-3989.
38. Hajishengallis, G., Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? Microbes. Infect. 2009, 11, 637-645.
39. Socransky, S. S., Haffajee, A. D., Dental biofilms: difficult therapeutic targets. Periodontol 2000. 2002, 28, 12-55.
40. Teles, R. P., Gursky, L. C., Faveri, M., Rosa, E. A. et al., Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis. J. Clin. Periodontol. 2010, 37, 313-323.